NeurologyLive Friday 5 — April 23, 2021

April 23, 2021
NeurologyLive Staff

Take 5 minutes to catch up on NeurologyLive's highlights from the week ending April 23, 2021.

Welcome to NeurologyLive's Friday 5! Every week, the staff compiles 5 highlights of NeurologyLive's widespread coverage in neurology, ranging from newsworthy study findings and FDA action to expert interviews and peer-to-peer panel discussions.

1: Trends in Movement Disorder Research: Ihtsham ul Haq, MD, FAAN

The chief of the Movement Disorders Division at the University of Miami Miller School of Medicine discussed some of the recently focused efforts to uncover more about Parkinson disease and what is on the horizon.

2: Peer Exchange: Strategies in Treating Relapsing-Remitting Multiple Sclerosis

Recommendations for appropriate treatment selection and use of high efficacy therapies as treatment for relapsing-remitting multiple sclerosis are given by a panel of Patricia K. Coyle, MD; Robert Fox, MD; and Clyde E. Markowitz, MD, moderated by Scott Newsome, DO, MSCS, FAAN.

3: NeuroVoices: Joseph Sirven, MD, on Expanding Research on Social Determinants of Health in Epilepsy

The professor of neurology at Mayo Clinic discussed the need for understanding more about how social determinants of health can impact epilepsy treatment delays, and detailed the results of his recent study that evaluated the role of these social determinants in epilepsy treatment delays for Arizonans on Medicaid.

4: Treatment Disparities, Neurologic Complications Clarified by COVID-19 Neurological Research

The 2021 AAN Meeting Hot Topics plenary focused on neurological facets of COVID-19 and featured insight from Anthony Fauci, MD, of NIAID, and Walter Koroshetz, MD, of NINDS, among others, highlighting the latest information on the complications of the infection.

5: Mind Moments Episode 34: Hope and the Huntington Disease Pipeline

"Mind Moments," a podcast from NeurologyLive, brings you an exclusive interview with Daniel Claassen, MD, MS, on the recent news of trial program terminations from Roche and Wave Life Science, and the hope that remains in the Huntington disease pipeline despite these setbacks.

—————————

Don't miss NeurologyLive's coverage of the 2021 American Academy of Neurology Annual Meeting! The virtual conference kicked off on Saturday, April 17, and ran through Thursday, April 22, but our team will be providing you with the news and top data beyond those dates, including interviews with experts in neurology. Catch up with all the latest here: AAN 2021.